US 6028106
Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents
expired A61KA61K31/198A61K31/21
Quick answer
US patent 6028106 (Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents) held by Board of Regents, The Univ. of TX System expires Mon Feb 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Board of Regents, The Univ. of TX System
- Grant date
- Tue Feb 22 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K31/198, A61K31/21, A61K31/295, A61K31/34